KEYNOTE: Progress in PH in lung disease: hope or hype?

Presented at PVRI 2026 Congress by Oksana Shlobin, Inova Fairfax Hospital

Summary

Explore the latest advancements in understanding PH and its connection to chronic lung diseases like ILD and COPD. The talk highlights challenges in patient phenotyping, the importance of innovative therapeutic approaches, and the need for improved clinical trial designs. Imaging plays a crucial role in understanding patient conditions, while recognising different phenotypes is essential for finding effective treatment. Dr. Lucilla Piccari’s contributions to the field of Group 3 PH are highlighted at the end of the talk.

Generated with AI, edited by PVRI